Position in CNTN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$103,005
New position
Shares Held
31,500
first reported quarter
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026VAN ECK ASSOCIATES CORP holds $332,748,136 across 30 Biotechnology names. CNTN ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
146,116 | $65,246,638 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
62,584 | $48,354,901 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
108,305 | $32,163,335 | |
| 4 | ARGX |
Argenx SE
|
40,397 | $29,499,909 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
54,137 | $17,912,308 | |
| 6 | INSM |
INSMED Inc
|
104,290 | $17,053,500 | |
| 7 | TECH |
BIO-TECHNE Corp
|
317,198 | $16,576,767 | |
| 8 | MRNA |
Moderna, Inc.
|
246,431 | $12,518,694 |
All Filings in CNTN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $103,005 | 31,500 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||